- Scispot has partnered with bioanalytical and biomarker contract research organization KCAS Bio to support its digital transformation through laboratory automation and connected workflows.
- Initial work will focus on automating scientific reporting, followed by a phased roadmap covering inventory, dose formulation analysis and connected laboratory workflows.
Scispot, a provider of AI-native laboratory operating systems, has partnered with KCAS Bio, a global bioanalytical and biomarker contract research organization, to support the company’s digital transformation. The collaboration will combine KCAS Bio’s scientific expertise with Scispot’s laboratory automation capabilities to address the evolving needs of pharmaceutical and biotechnology sponsors.
The initial phase will focus on automating scientific reporting, with subsequent work planned across inventory management, dose formulation analysis and connected laboratory workflows. The initiative aims to reduce repetitive data handling and report preparation, allowing scientists to dedicate more time to analysis, interpretation and sponsor collaboration. Progress will be assessed through workflow cycle time and capacity measures.
The initiative will build on KCAS Bio’s existing quality systems and independent quality assurance processes. Connected records and consistent documentation are intended to support data integrity, traceability and the scientific review processes required for compliant study delivery.
“The digital transformation investment is intended to support clients’ growing needs while maintaining quality.”
KCAS Bio CEO John Bucksath
“The collaboration will connect data and automate workflows so scientists can focus on their scientific work.”
Scispot founder and CEO Guru Singh
Sign up to the free weekly newsletter for all the latest news, resources and podcasts in contract manufacturing. 
